Literature DB >> 17689071

Human 3beta-hydroxysteroid dehydrogenase types 1 and 2: Gene sequence variation and functional genomics.

Liewei Wang1, Ezequiel Salavaggione, Linda Pelleymounter, Bruce Eckloff, Eric Wieben, Richard Weinshilboum.   

Abstract

The 3beta-hydroxysteroid dehydrogenase/Delta(5)-Delta(4) isomerase isoenzymes 1 and 2 (HSD3B1 and HSD3B2) are membrane-bound enzymes that play essential roles in the biosynthesis of steroid hormones. Therefore, variation in the HSD3B1 and HSD3B2 genes might play a role in the pathophysiology of steroid hormone-related disease. We set out to systematically identify common polymorphisms and haplotypes in human HSD3B1 and HSD3B2. We identified 17 single nucleotide polymorphisms (SNPs) in HSD3B1 and 9 in HSD3B2 - the majority of which were not present in public databases - by resequencing human HSD3B1 and HSD3B2 using 240 DNA samples from four different ethnic groups (60 samples per group). Functional genomic studies of the five non-synonymous cSNPs in HSD3B1 and the one observed in HSD3B2 showed that two of these polymorphisms resulted in significant decreases in the quantity of enzyme protein expressed. However, none of the three non-synonymous SNPs located in areas encoding putative membrane-binding domains altered subcellular localization of the enzyme as determined by immunofluorescence microscopy. Finally, common variant haplotypes in the 5'-flanking regions of these genes showed significant cell line-dependent variation in their ability to drive transcription. In aggregate, these results provide a basis for study of the possible role in human disease of common genetic variation in HSD3B1 and HSD3B2.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17689071      PMCID: PMC2755580          DOI: 10.1016/j.jsbmb.2007.03.037

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  43 in total

1.  Induction of 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13.

Authors:  S Gingras; R Moriggl; B Groner; J Simard
Journal:  Mol Endocrinol       Date:  1999-01

Review 2.  Molecular biology and genetics of the 3 beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene family.

Authors:  J Simard; F Durocher; F Mébarki; C Turgeon; R Sanchez; Y Labrie; J Couet; C Trudel; E Rhéaume; Y Morel; V Luu-The; F Labrie
Journal:  J Endocrinol       Date:  1996-09       Impact factor: 4.286

3.  Induction of 3beta-hydroxysteroid dehydrogenase/isomerase type 1 expression by interleukin-4 in human normal prostate epithelial cells, immortalized keratinocytes, colon, and cervix cancer cell lines.

Authors:  S Gingras; J Simard
Journal:  Endocrinology       Date:  1999-10       Impact factor: 4.736

Review 4.  Beta2-adrenoceptor gene polymorphisms.

Authors:  Otto-Erich Brodde; Kirsten Leineweber
Journal:  Pharmacogenet Genomics       Date:  2005-05       Impact factor: 2.089

5.  Stat5-mediated regulation of the human type II 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase gene: activation by prolactin.

Authors:  F A Feltus; B Groner; M H Melner
Journal:  Mol Endocrinol       Date:  1999-07

Review 6.  Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones.

Authors:  Anita H Payne; Dale B Hales
Journal:  Endocr Rev       Date:  2004-12       Impact factor: 19.871

Review 7.  The multiple murine 3 beta-hydroxysteroid dehydrogenase isoforms: structure, function, and tissue- and developmentally specific expression.

Authors:  A H Payne; I G Abbaszade; T R Clarke; P A Bain; C H Park
Journal:  Steroids       Date:  1997-01       Impact factor: 2.668

8.  Creation of a fully active, cytosolic form of human type I 3beta-hydroxysteroid dehydrogenase/isomerase by the deletion of a membrane-spanning domain.

Authors:  J L Thomas; B W Evans; G Blanco; J I Mason; R C Strickler
Journal:  J Mol Endocrinol       Date:  1999-10       Impact factor: 5.098

9.  Regulation of mammary gland factor/Stat5a during mammary gland development.

Authors:  A V Kazansky; B Raught; S M Lindsey; Y F Wang; J M Rosen
Journal:  Mol Endocrinol       Date:  1995-11

10.  Characterization of the 3 beta-hydroxysteroid dehydrogenase activity associated with bovine adrenocortical mitochondria.

Authors:  N Cherradi; G Defaye; E M Chambaz
Journal:  Endocrinology       Date:  1994-03       Impact factor: 4.736

View more
  8 in total

1.  Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.

Authors:  Jie Li; Emma Mercer; Xin Gou; Yong-Jie Lu
Journal:  Am J Cancer Res       Date:  2013-04-03       Impact factor: 6.166

2.  Proteasome beta subunit pharmacogenomics: gene resequencing and functional genomics.

Authors:  Liewei Wang; Shaji Kumar; Brooke L Fridley; Krishna R Kalari; Irene Moon; Linda L Pelleymounter; Michelle A T Hildebrandt; Anthony Batzler; Bruce W Eckloff; Eric D Wieben; Philip R Greipp
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

Review 3.  Molecular basis for prostate cancer racial disparities.

Authors:  Santosh K Singh; James W Lillard; Rajesh Singh
Journal:  Front Biosci (Landmark Ed)       Date:  2017-01-01

4.  Prediction of susceptibility to major depression by a model of interactions of multiple functional genetic variants and environmental factors.

Authors:  M-L Wong; C Dong; V Andreev; M Arcos-Burgos; J Licinio
Journal:  Mol Psychiatry       Date:  2012-03-27       Impact factor: 15.992

5.  The proteome of cytosolic lipid droplets isolated from differentiated Caco-2/TC7 enterocytes reveals cell-specific characteristics.

Authors:  Julien Bouchoux; Frauke Beilstein; Thomas Pauquai; I Chiara Guerrera; Danielle Chateau; Nathalie Ly; Malik Alqub; Christophe Klein; Jean Chambaz; Monique Rousset; Jean-Marc Lacorte; Etienne Morel; Sylvie Demignot
Journal:  Biol Cell       Date:  2011-11       Impact factor: 4.458

6.  Genetic Testing for a Patient with Suspected 3 Beta-Hydroxysteroid Dehydrogenase Deficiency: A Case of Unreported Genetic Variants.

Authors:  Elisa Menegatti; Daniele Tessaris; Alice Barinotti; Patrizia Matarazzo; Silvia Einaudi
Journal:  J Clin Med       Date:  2022-09-29       Impact factor: 4.964

7.  Albuminuria is associated with too few glomeruli and too much testosterone.

Authors:  David A Long; Maria Kolatsi-Joannou; Karen L Price; Cecile Dessapt-Baradez; Jennifer L Huang; Eugenia Papakrivopoulou; Mike Hubank; Ron Korstanje; Luigi Gnudi; Adrian S Woolf
Journal:  Kidney Int       Date:  2013-02-27       Impact factor: 10.612

8.  HSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancer.

Authors:  Angeline S Andrew; Ting Hu; Jian Gu; Jiang Gui; Yuanqing Ye; Carmen J Marsit; Karl T Kelsey; Alan R Schned; Sam A Tanyos; Eben M Pendleton; Rebecca A Mason; Elaine V Morlock; Michael S Zens; Zhongze Li; Jason H Moore; Xifeng Wu; Margaret R Karagas
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.